Search

everythinglearnresearchcommunity

for

Search:↓

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

The same genetic mutation in Sjögren-Larsson syndrome can lead to different levels of severity, suggesting other factors influence the symptoms.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

Probiotics may help manage celiac disease by improving gut health and reducing symptoms.

Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.

Targeting endolysosomes may help treat COVID-19.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Adrenal disorders can cause lasting brain and behavior issues in children.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Formononetin may help protect the brain and treat neurological diseases.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Exposure to toxic elements like mercury and lead may be linked to autism, and a higher zinc to copper ratio might help protect against it.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Glioblastoma cells can make androgens, which might help the tumor grow.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.